GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Framework

EHS and EHM vision

Environment, health and safety policy

Planning
The EHS Plan for Excellence
Targets

Organisation

Management systems

Programmes

Audit

Stakeholder communication

Reward and recognition

Issues

Performance

Verification statement

Index

Planning
Previous
Next
 
 

Strategy
GSK's EHS strategy of continuous improvement supports corporate social responsibility and encourages a sustainable business culture. It is based on the principles of the GSK Spirit:

  • Passion: GSK works to protect people and the environment in a company dedicated to improving the quality of human life.
  • Sense of Urgency: The absence of EHS programmes could endanger the lives and health of our employees and the quality of the environment.
  • Entrepreneurial: We look for new ways of working throughout the organisation - from R&D to manufacturing to sales - in order to improve our efficiency.
  • Innovation: We want to be among the leaders in the way we manage our EHS responsibilities by adopting new approaches to chemistry, manufacturing processes, waste treatment, safe working, transparent reporting and everything we do.
  • Integrity: We include our responsibility for good environment, health and safety management in our definition of integrity. It is fundamentally the right thing to do.
Dr. David Pulman "In manufacturing, our employees can be at risk from many hazards. It is my responsibility to ensure that all manufacturing operations are managed safely and that a culture of proactive risk minimisation is established. Employee health and safety is a key business priority and must be at the forefront of all managers' and staffs' activities. Equally, we must ensure that all resources are used responsibly and efficiently so that the environment and communities in which we operate are not at risk from emissions and process waste. A significant amount of our technical effort is focussed on minimising waste. By safeguarding our staff, and using resources in an efficient manner, we will move further down the track of sustainable and responsible manufacturing. This is good for patients, shareholders, employees, communities and the environment - and hence good for our business. This will continue to be a focus in the future." Dr. David Pulman, President, Global Manufacturing and Supply

The EHS strategy also aligns with GSK's five business drivers:

People
The single greatest source of competitive advantage is GSK's people. It is vital that we protect the health and safety of employees, contractors, visitors and others affected by our operations. We will design our facilities and processes, conduct risk assessments and provide training in order to eliminate work-related safety and health hazards. We will focus on employee health enhancement, mental well-being, causes of absence and methods of rehabilitation in order to have a productive and resilient work force.

New Product Portfolio
Our new products are carefully designed to help millions of people around the world live longer, healthier and happier lives. To treat disease, the products must have biological activity and as a result have potential EHS risks and impacts throughout their life cycle i.e. from raw material acquisition to R&D and manufacturing through to patient use and disposal. We will apply the principles of product stewardship throughout our organisation to deliver positive EHS benefits and minimise risks to our business, people and the environment. Product stewardship encompasses the assessment of the health, safety (excluding patient safety which is assessed separately), and environmental risks created during all stages of the product's life cycle and in particular at the key decision stages in R&D. We will also apply product stewardship principles to our contract manufacturers and key suppliers.

Product Commercialisation
Environment, health and safety play an important role in commercialising products. By integrating environment, health and safety planning into decision-making on manufacturing processes, packaging design and product labelling, we help differentiate our products and protect and extend product life cycles. By fully embracing EHS principles, the sales organisation can minimise the cost of motor vehicle accidents and maximise the productivity of sales and distribution staff while optimising their environmental efficiency.

Global Competitor
As a global competitor, GSK seeks to be a leader in EHS within the pharmaceutical and consumer health sectors by applying best business processes globally and fostering a culture of continuous improvement. As a global corporate citizen, we will demonstrate our commitment to corporate responsibility by implementing global standards, guidelines, targets and management systems, auditing our programmes and reporting publicly and openly on performance. We will seek dialogue with external stakeholders and consider their views when developing our approaches to EHS management.

Operational Excellence
GSK's operations must achieve legal compliance with EHS regulations. In the spirit of operational excellence they must also continuously improve performance particularly in the areas of accident and occupational illness prevention, waste minimisation and emissions reductions. We seek to integrate EHS aspects into GSK's business processes, such as capital planning, decision-making, purchasing, training and communications.



Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement